Latest UT Southwestern Medical Center Stories
DALLAS, June 8, 2011 /PRNewswire-USNewswire/ -- Dr.
Blocking two tiny molecules of RNA â€“ a chemical cousin of DNA â€“ appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found.
In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.
A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia.
A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.
UT Southwestern Medical Center researchers are engaging the help of professional boxers and trainers to study whether a component in red wine and grapes could help reduce the short- and long-term effects of concussions.
A gynecologist and a molecular biologist at UT Southwestern Medical Center have collaborated to show for the first time that pelvic organ prolapse â€“ a condition in which the uterus, bladder or vagina protrude from the body â€“ is caused by a combination of a loss of elasticity and a breakdown of proteins in the vaginal wall.
Ray Johnston's goal in three years is for his band to sell out at the 1,600-seat House of Blues in Dallas.
If youâ€™re middle-aged, the answer could provide a strong predictor of your risk of heart attack or stroke over the next decade or more.
A cancer drug already used to treat adults and school-age children with sickle cell anemia is safe and significantly reduces pain and other complications of the disease in children as young as 9 months.